MAPT and Alzheimer disease: It showed that T2DM brain had a decreased level of neuronal GLUT3 protein compared with the AD brain and that the decreased O-GlcNAcylation (inhibiting tau protein) observed in the AD brain was also visible in the T2DM (50).